RecruitingNCT06679777

Swedish CArdioPulmonary bioImage Study 2


Sponsor

Karolinska Institutet

Enrollment

30,154 participants

Start Date

Jan 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

In the Swedish CArdioPulmonary bioImage Study (SCAPIS 1), 30,154 randomly selected men and women, aged 50-64 years, were recruited from six areas in Sweden during 2013-2018. The study population was investigated with CCTA, ultrasound carotids, physical examination, questionnaires, accelerometry, ECG, spirometry, and biochemical markers. The aim was to obtain new information relevant to the identification and treatment of individuals with cardiopulmonary and metabolic diseases and to optimize the possibilities for studying disease mechanisms. In SCAPIS-2, half of the individuals (n≈15,000) included in SCAPIS 1, will be re-examined 2024-2025 with the same investigations as during 2013-2018 except for ultrasound of the carotids.


Eligibility

Inclusion Criteria1

  • \- Participated in SCAPIS 1.

Exclusion Criteria1

  • Individuals who have withdrawn their informed consent during or after SCAPIS 1.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Gothenburg University

Gothenburg, Sweden

Linköping University

Linköping, Sweden

Lund University

Lund, Sweden

Karolinska Institutet

Stockholm, Sweden

Umeå Universitet

Umeå, Sweden

Uppsala University

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06679777


Related Trials